Transformation properties of the ETO gene, Fusion partner in t(8:21) Leukemias

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2951-2955

  Wang, Jianxiang ^a   Wang, Min ^b   Liu, Johnson M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CHROMOSOME TRANSLOCATION 8; GENE FUSION; GENE LOCUS; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; CLONING, MOLECULAR; DNA-BINDING PROTEINS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICE; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS; RABBITS; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 0030787009     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Nucifora, G., and Rowley, J. D. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood, 86: 1-14, 1995.
2. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. The t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia clustered within a limited region of a novel gene, AML1. Proc. Natl. Acad. Sci. USA, 88: 10431-10434, 1991.
3. Erickson, P., Gao, J., Chang, K-S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. D., and Drabkin, H. Identification of breakpoints in t(8;21) AML and isolation of a fusion transcript with similarity to Drosaphila segmentation gene runt. Blood, 80: 1825-1831, 1992.
4. Nisson, P. E., Watkins, P. C., and Sacchi, N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in the t(8;21) leukemic cells. Cancer Genet. Cytogenet., 63: 81-88, 1992.
5. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N., and Ohki, M. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 transcript. EMBO J., 12: 2715-2721, 1993.
6. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. AML-1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84: 321-330, 1996.
7. Kagoshima, H., Shigesada, K., Satake, M., Ito, Y., Miyoshi, H., Ohki, M., Pepling, M., and Gergen, P. The runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet., 9: 338-341, 1993.
8. Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., and Hirai, H. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J., 14: 341-350, 1995.
9. Erickson, P. F., Robinson, M., Owens, G., and Drabkin, H. A. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res., 54: 1782-1786, 1994.
10. Evans, R. M., and Hollenberg, S. M. Zinc fingers: gilt by association. Cell, 52: 1-3, 1988.
11. Berg, J. M. Zinc fingers and other metal-binding domains. Elements for interaction between macromolecules. J. Biol. Chem., 265: 6513-6516, 1990.
12. Owens, G. P., Hahn, W. E., and Cohen, J. J. Identification of mRNA associated with programmed cell death in immature thymocytes. Mol. Cell. Biol., 11: 4177-4188, 1991.
13. Era, T., Asou, N., Kunisada, T., Yamasaki, H., Asou, H., Kamada, N., Nishikawa, S-I., Yamaguchi, K., and Takatsuki, K. Identification of two transcripts of AML1/ ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer, 13: 25-33, 1995.
14. Erickson, P. F., Dessev, G., Lasher, R. S., Philips, G., Robinson, M., and Drabkin, H. A. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease Blood, 88: 1813-1823, 1996.
15. Wigler, M., Pellicer, A., Silverstein, S., and Axel, R. Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor. Cell, 14: 725-731, 1978.
16. Coligan, J. E., Kruisbeek, A. M., Margulies, D. H., Shevach, E. M., and Strober, W. (eds.). Current Protocols in Immunology, Vol. 2, pp. 9.3.4-9.3.5. New York: John Wiley, 1992.
17. Harlow, E., and Lane, D. (eds.). Antibodies: A Laboratory Manual, pp. 421-511. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
18. Sambrook, J., Fritsch, E. F., and Maniatis, T. (eds.). Molecular Cloning: A Laboratory Manual, Ed. 2, pp. 7.37, 9.31-9.57. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
19. Kamps, M. P., Look, A. T., and Baltimore, D. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev., 5: 358-368, 1991.
20. Watanabe, S., Shimosato, Y., Kuroki, M., Sato, Y., Nakajima, T. Transplantability of human lymphoid cell line, lymphoma, and leukemia in splenectomized and/or irradiated nude mice. Cancer Res., 40: 2588-2595, 1980.
21. Sakakura, C. Yamaguchi-Iwai, Y., Satake, M., Bae, S-C., Takahashi, A., Ogawa, E., Hagiwara, A., Takahashi, T., Murakami, A., Makino, K., Nakagawa, T., Kamada, N., and Ito, Y. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proc. Natl. Acad. Sci. USA 91: 11723-11727, 1994.
22. Lenny, N., Meyers, S., and Hiebert, S. W. Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene, 11: 1761-1769, 1995.
23. Meyers, S., Lenny, N., and Hiebert, S. W. The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol. Cell Biol., 15: 1974-1982, 1995.
24. Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soeda, E., and Ohki, M. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res., 23: 2762-2769, 1995.
25. Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S. W., and Nimer, S. D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene, 11: 2667-2674, 1995.
26. Yergeau, D. A., Hetherington, C. J., Wang, Q., Zhang, P., Sharpe, A. H., Binder, M., Marin-Padilla, M., Tenen, D. G., Speck, N. A., and Zhang, D-E. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat. Genet., 15: 303-306, 1997.
27. Kurokawa, M., Tanaka, T., Tanaka, K., Ogawa, S., Mitani, K., Yazaki, Y., and Hirai, H. Overexpresision of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies. Oncogene, 12: 883-892, 1996.
28. Rhoades, K. L., Hetherington, C. J., Rowley, J. D., Hiebert, S. W., Nucifora, G., Tenen, D. G., and Zhang, D-E. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proc. Natl. Acad. Sci. USA, 93: 11895-11900, 1996.
29. Klampfer, L., Zhang, J., Zelenetz, A. O., Uchida, H., Nimer, S. D. The AML1/ETO fusion protein activates transcription of BCL-2. Proc. Natl. Acad. Sci. USA, 93: 14059-14064, 1996.